🇫🇷 SAN.PA — Sanofi

Healthcare Compra
← Volver

Precio actual

76,26 EUR

Máx. histórico

110,88

543 días

Caída desde máximo

-31,22%

Rango 52 semanas

71,25 – 91,15

Variación hoy

-0,01%

Cierre anterior

76,27

Rango de hoy

75,90 – 76,65

Volumen hoy

1.490.914

Información
Nombre completo
Sanofi
Divisa
EUR
Mercado
Paris
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
74.846
PER ⓘ
23,54 (puede no estar actualizado)
Dividend yield
5,40% (puede no estar actualizado)
Precio objetivo analistas
94,28 EUR (puede no estar actualizado)
Primera cotización
03/01/2000
Precio actualizado
hace 3 días
Sobre la empresa

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Dividendos repartidos Total últimos 12 meses: 4,1200 EUR · Yield: 5,40%
Fecha de pago Importe por participación
05/05/2026 4,1200 EUR
12/05/2025 3,9200 EUR
13/05/2024 3,7600 EUR
30/05/2023 3,5600 EUR
06/05/2022 3,3300 EUR
05/05/2021 3,2000 EUR
04/05/2020 3,1500 EUR
09/05/2019 3,0700 EUR
11/05/2018 3,0300 EUR
16/05/2017 2,9600 EUR
10/05/2016 2,9300 EUR
11/05/2015 2,8500 EUR
12/05/2014 2,8000 EUR
09/05/2013 2,7700 EUR
10/05/2012 2,6500 EUR
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/04/2011 52,91 53,24 52,59 52,97 +0,17% 1,22% 3.021.125
26/04/2011 52,23 52,93 51,92 52,88 +0,83% 1,94% 2.999.714
21/04/2011 52,21 52,59 52,11 52,44 +0,44% 0,93% 2.719.678
20/04/2011 51,24 52,30 51,24 52,21 +2,56% 2,08% 3.672.507
19/04/2011 50,89 51,18 50,60 50,91 +0,81% 1,13% 2.793.588
18/04/2011 51,66 51,82 50,31 50,50 -2,08% 2,93% 4.263.507
15/04/2011 50,75 51,72 50,72 51,58 +1,35% 1,96% 4.314.978
14/04/2011 50,73 50,97 50,44 50,89 -0,51% 1,04% 2.505.310
13/04/2011 50,87 51,33 50,81 51,15 +0,47% 1,02% 2.549.265
12/04/2011 50,92 51,49 50,82 50,91 -0,16% 1,31% 4.332.779
11/04/2011 50,28 51,29 50,28 50,99 +1,04% 2,02% 3.117.484
08/04/2011 50,28 50,55 50,16 50,46 +0,57% 0,79% 2.097.381
07/04/2011 50,37 50,59 50,01 50,18 -0,20% 1,16% 2.813.579
06/04/2011 50,20 50,60 50,05 50,28 -0,06% 1,11% 2.391.839
05/04/2011 49,78 50,35 49,75 50,31 +0,84% 1,20% 2.679.385
04/04/2011 49,98 50,14 49,83 49,89 -0,24% 0,62% 2.151.113
01/04/2011 50,01 50,16 49,37 50,01 +1,63% 1,57% 3.270.687
31/03/2011 49,43 49,69 49,21 49,21 -0,49% 0,98% 3.006.977
30/03/2011 49,23 49,65 49,23 49,45 +1,37% 0,87% 2.771.850
29/03/2011 48,83 49,03 48,37 48,78 -0,01% 1,35% 2.542.082
28/03/2011 48,77 49,28 48,66 48,79 -0,09% 1,27% 2.230.759
25/03/2011 48,35 49,00 48,18 48,83 +1,15% 1,70% 3.241.020
24/03/2011 47,52 48,38 47,17 48,28 +1,58% 2,55% 2.740.254
23/03/2011 47,16 47,95 47,12 47,53 +0,27% 1,76% 2.492.043
22/03/2011 47,53 47,88 47,12 47,40 -0,70% 1,59% 2.725.234
21/03/2011 47,24 47,79 47,15 47,73 +1,86% 1,36% 2.998.719
18/03/2011 47,00 47,63 46,62 46,86 -0,31% 2,15% 6.691.610
17/03/2011 46,26 47,31 46,02 47,00 +2,47% 2,79% 5.392.158
16/03/2011 46,65 46,95 45,79 45,87 -1,52% 2,48% 5.690.234
15/03/2011 47,24 47,73 45,82 46,58 -3,24% 4,04% 8.357.603